Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pris

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Leukemia|April 1, 1994
Potential strategies for circumventing myeloperoxidase-catalyzed degradation of vinca alkaloidsD Schlaifer, M R Cooper, M Attal, et al.
Blood|October 1, 1986
t(14;14)(q11;q32) in biphenotypic blastic phase of chronic myeloid leukemiaN Dastugue, E Kuhlein, E Duchayne, et al.
La Nouvelle Presse Medicale|October 14, 1972
[Abnormalities of platelet aggregation during essential thrombocythemia. Effect of aspirin on erythromelalgia]B Boneu, J Pris, B Guiraud, et al.
Annales De Medecine Interne|January 1, 1990
[Fulminating hepatitis by type 5 adenoviruses during Hodgkin's disease]K Bouabdallah, F Rigal-Huguet, C Alard, et al.
Pathologie-Biologie|September 1, 1988
[Initial antibacterial prophylaxis after bone marrow allograft. Pilot study with systemic vancomycin]H Rubie, M Attal, J Lemozy, et al.
Scandinavian Journal of Haematology|September 1, 1980
Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function testsB Boneu, C Nouvel, P Sie, et al.
Blood|October 15, 1994
Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin's diseaseP Brousset, D Schlaifer, F Meggetto, et al.
Lancet (London, England)|October 27, 1984
Essential thrombocythaemia and recurrent myocardial infarctionP Douste-Blazy, M J Taudou, M Delay, et al.
Blood|August 1, 1993
Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trialM Attal, F Huguet, H Rubie, et al.
Cancer Genetics and Cytogenetics|October 1, 1992
t(9;11)(p22;q23) translocation in blastic phase of chronic myeloid leukemiaN Dastugue, E Duchayne, F Huguet, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Leukemia|April 1, 1994
Potential strategies for circumventing myeloperoxidase-catalyzed degradation of vinca alkaloidsD Schlaifer, M R Cooper, M Attal, et al.
Blood|October 1, 1986
t(14;14)(q11;q32) in biphenotypic blastic phase of chronic myeloid leukemiaN Dastugue, E Kuhlein, E Duchayne, et al.
La Nouvelle Presse Medicale|October 14, 1972
[Abnormalities of platelet aggregation during essential thrombocythemia. Effect of aspirin on erythromelalgia]B Boneu, J Pris, B Guiraud, et al.
Annales De Medecine Interne|January 1, 1990
[Fulminating hepatitis by type 5 adenoviruses during Hodgkin's disease]K Bouabdallah, F Rigal-Huguet, C Alard, et al.
Pathologie-Biologie|September 1, 1988
[Initial antibacterial prophylaxis after bone marrow allograft. Pilot study with systemic vancomycin]H Rubie, M Attal, J Lemozy, et al.
Scandinavian Journal of Haematology|September 1, 1980
Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function testsB Boneu, C Nouvel, P Sie, et al.
Blood|October 15, 1994
Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin's diseaseP Brousset, D Schlaifer, F Meggetto, et al.
Lancet (London, England)|October 27, 1984
Essential thrombocythaemia and recurrent myocardial infarctionP Douste-Blazy, M J Taudou, M Delay, et al.
Blood|August 1, 1993
Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trialM Attal, F Huguet, H Rubie, et al.
Cancer Genetics and Cytogenetics|October 1, 1992
t(9;11)(p22;q23) translocation in blastic phase of chronic myeloid leukemiaN Dastugue, E Duchayne, F Huguet, et al.
Pageof 11